Ventilation management and outcomes in out-of-hospital cardiac arrest: a protocol for a preplanned secondary analysis of the TTM2 trial

Chiara Robba, Niklas Nielsen, Josef Dankiewicz, Rafael Badenes, Denise Battaglini, Lorenzo Ball, Iole Brunetti, Wendel Garcia Pedro David, Paul Young, Glenn Eastwood, Michelle S. Chew, Janus Jakobsen, Johan Unden, Matthew Thomas, Michael Joannidis, Alistair Nichol, Andreas Lundin, Jacob Hollenberg, Gisela Lilja, Naomi E. HammondManoj Saxena, Annborn Martin, Miroslav Solar, Fabio Silvio Taccone, Hans A. Friberg, Paolo Pelosi

Research output: Contribution to journalArticleOtherpeer-review

3 Citations (Scopus)


INTRODUCTION: Mechanical ventilation is a fundamental component in the management of patients post cardiac arrest. However, the ventilator settings and the gas-exchange targets used after cardiac arrest may not be optimal to minimise post-anoxic secondary brain injury. Therefore, questions remain regarding the best ventilator management in such patients. METHODS AND ANALYSIS: This is a preplanned analysis of the international randomised controlled trial, targeted hypothermia versus targeted normothermia after out-of-hospital cardiac arrest (OHCA)-target temperature management 2 (TTM2). The primary objective is to describe ventilatory settings and gas exchange in patients who required invasive mechanical ventilation and included in the TTM2 trial. Secondary objectives include evaluating the association of ventilator settings and gas-exchange values with 6 months mortality and neurological outcome. Adult patients after an OHCA who were included in the TTM2 trial and who received invasive mechanical ventilation will be eligible for this analysis. Data collected in the TTM2 trial that will be analysed include patients' prehospital characteristics, clinical examination, ventilator settings and arterial blood gases recorded at hospital and intensive care unit (ICU) admission and daily during ICU stay. ETHICS AND DISSEMINATION: The TTM2 study has been approved by the regional ethics committee at Lund University and by all relevant ethics boards in participating countries. No further ethical committee approval is required for this secondary analysis. Data will be disseminated to the scientific community by abstracts and by original articles submitted to peer-reviewed journals. TRIAL REGISTRATION NUMBER: NCT02908308.

Original languageEnglish
Article numbere058001
Number of pages7
JournalBMJ Open
Issue number3
Publication statusPublished - 3 Mar 2022


  • adult intensive & critical care
  • clinical trials
  • respiratory physiology

Cite this